Somerset, N.J. – Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, has today ...
Catalent, Inc. CTLT recently announced that it has expanded its primary packaging capabilities at its clinical supply facility in Shiga, Japan. The company has installed a high-speed blister packaging ...
Catalent hustled to expand its manufacturing capacity last year as it juggled a surge of COVID-19 work with its regular production orders. That pandemic agenda caused problems in December, when the ...
SOMERSET, N.J., Dec. 3, 2018 /PRNewswire-PRWeb/ -- Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer ...
SOMERSET, N.J.--(BUSINESS WIRE)--Catalent, Inc. (NYSE: CTLT), the leader in enabling the development and supply of better treatments for patients worldwide, today announced it has completed expansion ...
Catalent reported that it increased cold chain packaging capabilities at its Philadelphia facility to support the growing increased demand for the distribution of biologic drugs, and advanced cell and ...
SOMERSET, N.J.--(BUSINESS WIRE)--Catalent Pharma Solutions, Inc. announced today the appointment of Barry D. Russell as Group President, Commercial Packaging, effective May 1, 2010. Mr. Russell will ...
Somerset, N.J. — Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, has today ...
Somerset-based Catalent on Thursday said it completed a $14 million expansion at its Bloomington, Ind. facility. The provider of delivery technologies, development and manufacturing solutions for ...
With a suite of drugmakers looking for manufacturing partners in the hunt for a COVID-19 vaccine, major contract manufacturers are stepping in to help handle the load. One of those, New Jersey's ...
Catalent, the leader in enabling the development and supply of better treatments for patients worldwide, today announced that it has expanded its integrated development, manufacturing and supply ...
The expansion increases the site’s footprint by 32,000 square feet (3,000 square meters), adding storage and handling of clinical trial supply materials at controlled room temperatures between 15 and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results